- Category
- Medium (2024-25)
- Udyam number
- UDYAM-HR-13-0000327

About SCL Lifesciences Limited
Data last updated:
SCL Lifesciences Limited is a public limited company based in Punjab, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 20 December 1993 and has been in existence for over 33 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24112PB1993PLC014017. Its GSTIN is 03AACCS4745B1ZU (Punjab). The company holds 15 GST registrations, of which 5 are active.
The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹5 Cr. It was formerly known as Saurav Chemicals Private Limited. It is led by directors including Parveen Goyal (Managing Director) and Udayan Sengupta (Whole-Time Director).
Its last annual general meeting (AGM) was held on 15 June 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Vill Saidpuradera Bassi Barwala Road Dera Bassi, Punjab, India.
As per the financials filed for FY 2026, the company reported a revenue of ₹305.27 Cr, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹58.4 Cr (net margin 19.1%) and EBITDA of ₹86.63 Cr (EBITDA margin 28.4%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 1% over five years.
The company has about 862 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: SCL Lifesciences. As per MCA filings, the company has open charges of ₹30.75 Cr and satisfied charges of ₹109.32 Cr on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it; 1 case is pending. The company has 14 deals on record (10 secondary share transfers, 2 rights issues, 2 funding rounds), with disclosed funding of ₹15.2 Cr; the latest was in April 2024. Its 6 peer companies in the Pharma industry (API Manufacturers, Lifesciences), with the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations) are compared by revenue, 3 larger and 3 smaller; the largest is R.L.Fine Chem Private Limited with revenue of ₹360.48 Cr. The company has 21 MSME Form 1 returns on record between 2019 and 2024, listing 61 overdue payments to 37 micro and small suppliers.
SCL Lifesciences Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-13-0000327). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sauravchemicals.com.
Company details
CIN history
SCL Lifesciences has one previous CIN (Corporate Identification Number): L24112PB1993PLC014017. The current CIN is U24112PB1993PLC014017, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24112PB1993PLC014017 | Current |
| L24112PB1993PLC014017 | Previous |
Recognitions & Rankings of SCL Lifesciences
Contact details
SCL Lifesciences Limited's registered office is in Punjab. Its website is sauravchemicals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressVill Saidpuradera Bassi Barwala Road Dera Bassi, Punjab, India
- IndustryPharma, API Manufacturers
To see the full contact details of SCL Lifesciences Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
SCL Lifesciences operates one associated brand: SCL Lifesciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Contract-based manufacturing services for active pharmaceutical ingredients are provided. | sauravchemicals.com |
Business activity
The main business activity of SCL Lifesciences is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of SCL Lifesciences Limited, buy the company report.
Financials of SCL Lifesciences Limited
FY 2026 filings availableSCL Lifesciences Limited reported revenue of ₹305.27 Cr (down 10% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue fell 10% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 1%. EBITDA rose 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹305.27 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹86.63 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹58.4 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 28.4% | ||||
| Net Profit Margin | 19.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of SCL Lifesciences Limited, buy the company report.
Board of directors of SCL Lifesciences Limited
SCL Lifesciences has 9 current directors and 17 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Udayan Sengupta | Whole-Time Director | 04 Oct 2005 | 21 Years 1 Months | Current |
| Nitish Mukherjee | Director | 20 Nov 2018 | 7 Years 11 Months | Current |
| Sameer Singla Also directs: Revayu Systems Private Limited | Director | 14 Feb 2019 | 7 Years 9 Months | Current |
| Naohiro Yoshida Also directs: Iffco-Mc Crop Science Private Limited | Director | 25 Aug 2021 | 5 Years 2 Months | Current |
| Parveen Goyal Also directs: Mohali Green Environment Private Limited | Managing Director | 01 Apr 2012 | 14 Years 7 Months | Current |
| Vijay Dilbagh Rai Also directs: Punjab Chemicals and Crop Protection Limited, Calibre Chemicals Private Limited, Pimex India Private Limited and 1 more | Director | 14 Feb 2017 | 9 Years 9 Months | Current |
Peer comparison
SCL Lifesciences Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (API Manufacturers, Lifesciences), with the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| R.L.Fine Chem Private Limited | ₹360.48 Cr (FY 2025) | 6.0% | Bangalore, Karnataka, India | |||
| Tirupati Lifesciences Private Limited | ₹350.76 Cr (FY 2025) | 12.0% | Paonta Sahib, Himachal Pradesh, India | |||
| Haleos Labs Limited | ₹349.58 Cr (FY 2025) | 13.0% | Hyderabad, Telangana, India | |||
| Valiant Laboratories Limited | ₹338.77 Cr (FY 2023) | 61.0% | Mumbai, Maharashtra, India | |||
| Mangalam Drugs and Organics Limited | ₹318.73 Cr (FY 2025) | -14.0% | Mumbai, Maharashtra, India | |||
| Saraca Laboratories Limited | ₹310.45 Cr (FY 2025) | 11.0% | Hyderabad, Telangana, India | |||
| SCL Lifesciences Limitedthis company | ₹305.27 Cr (FY 2026) | ₹58.4 Cr | 19.1% | -10.0% | 862 | Punjab, India |
To see the full peer comparison of SCL Lifesciences Limited, buy the company report.
Auditor
SCL Lifesciences Limited is audited by S.Tandon & Associates for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.Tandon & Associates | FY 2026 | 006388N |
Shareholding
The shareholding of SCL Lifesciences Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of SCL Lifesciences Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Jun 2014 | 10510845 | The Hongkong and Shanghai Banking Corporation Limited | ₹10 Cr | Open | |
| 18 Feb 2013 | 10407458 | Hdfc Bank Limited | ₹20.75 Cr | Open | |
| 30 Sep 2016 | 100056779 | State Bank of India | ₹14 Cr | Satisfied | |
| 28 Oct 2014 | 10530435 | The Hongkong and Shanghai Banking Corporation Limited | ₹1.85 Cr | Satisfied | |
| 14 Aug 2014 | 10521874 | Hdfc Bank Limited | ₹5.75 Cr | Satisfied |
To see the full charge records of SCL Lifesciences Limited, buy the company report.
Total charge records: 27 View all charges
Deals & funding
SCL Lifesciences Limited has 14 deals on record (10 secondary share transfers, 2 rights issues, 2 funding rounds), with disclosed funding of ₹15.2 Cr; the latest was in April 2024.
Deals on record (5 of 14)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Apr 2024 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: Parveen Goyal & Sons HUF |
| Jun 2020 | Secondary share transfer | Undisclosed | Buyer: Goyal Family Trust Seller: an individual |
| Aug 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Aug 2016 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Mar 2011 | Rights issue | ₹2.55 Cr | Investors: Indian Voice Private Limited , 3 individuals |
To see the full deal history of SCL Lifesciences Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
SCL Lifesciences Limited has 2 court cases on record: 1 filed by SCL Lifesciences, 1 filed against it. 1 case is pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 1 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mohali, Punjab | Civil suit | Filed against the company by Somany Bath Fittings Pvt Ltd | Pending |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against an individual | Disposed |
To see the full case history of SCL Lifesciences Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
SCL Lifesciences Limited was last rated by Crisil on 25 Sep 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 25 Sep 2020 |
To see the full credit ratings and regulatory alerts of SCL Lifesciences Limited, buy the company report.
MSME payment delays
SCL Lifesciences Limited has 21 MSME Form 1 returns on record between 2019 and 2024, listing 61 overdue payments to 37 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 37)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Shiva Scientific Glass Private Limited | |||
| Radix Electrosystems Pvt Ltd | |||
| Iee Elevators Private Limited | |||
| Sanco Infra Projects |
To see the full MSME payment records of SCL Lifesciences Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
SCL Lifesciences Limited has a workforce of 862 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 862 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of SCL Lifesciences Limited, buy the company report.
GST
SCL Lifesciences has 15 GST registrations: 5 active and 10 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AACCS4745B1ZU | Punjab | Active | 01 Jul 2017 |
| 06AACCS4745B3ZM | Haryana | Active | 02 Jul 2017 |
| 06AACCS4745B4ZL | Haryana | Active | 28 Aug 2017 |
| 09AACCS4745B1ZI | Uttar Pradesh | Active | 30 Dec 2021 |
To see the full GST registrations and return filing status of SCL Lifesciences Limited, buy the company report.
Recent activity
SCL Lifesciences Limited has 27 board changes on record since 2004: 12 appointments and 15 cessations. The latest: Anil Chaudhry was appointed as Director on 16 Jul 2025.
80 earlier events are in the company report.
Frequently asked questions
SCL Lifesciences is an active public limited company based in Punjab, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 20 December 1993 (33+ years old) and is registered under CIN U24112PB1993PLC014017.
SCL Lifesciences has 9 current directors:
- Parveen Goyal - Managing Director
- Udayan Sengupta - Whole-Time Director
- Saurav Goyal - Whole-Time Director
- Nitish Mukherjee - Director
- Sameer Singla - Director
- Naohiro Yoshida - Director
- Vijay Dilbagh Rai - Director
- Anil Chaudhry - Director
- Shweta Mehta - Director
The latest financial statements of SCL Lifesciences on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 15 June 2026. Year-wise statements from 2015 are in the company report.
The GSTIN of SCL Lifesciences is 03AACCS4745B1ZU, registered in Punjab. The company has 15 GST registrations in all, of which 5 are active and 10 are cancelled or inactive. Other active GSTINs include 06AACCS4745B3ZM (Haryana), 06AACCS4745B4ZL (Haryana), 09AACCS4745B1ZI (Uttar Pradesh).
The CIN (Corporate Identification Number) of SCL Lifesciences is U24112PB1993PLC014017. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
SCL Lifesciences has 2 court cases on record: 1 filed by the company and 1 filed against it. 1 is pending.
SCL Lifesciences was incorporated on 20 December 1993, making it 33+ years old. It is registered with the Registrar of Companies, Chandigarh.
SCL Lifesciences has 14 deals on record (10 secondary share transfers, 2 rights issues, 2 funding rounds), with disclosed funding of ₹15.2 Cr; the latest was in April 2024.
The peers of SCL Lifesciences by revenue are R.L.Fine Chem Private Limited, Tirupati Lifesciences Private Limited, Haleos Labs Limited, Valiant Laboratories Limited, Mangalam Drugs and Organics Limited and 1 more, all in the Pharma industry (API Manufacturers, Lifesciences), with the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Anil Chaudhry was appointed as Director on 16 Jul 2025. Shweta Mehta was appointed as Director on 28 Aug 2023. Kamal Kant Gambhir was appointed as CFO on 01 Aug 2022. SCL Lifesciences has 27 board changes on record in total.
Yes, SCL Lifesciences is registered as a medium enterprise under Udyam registration (number: UDYAM-HR-13-0000327).
SCL Lifesciences has 21 MSME Form 1 returns on record between 2019 and 2024, listing 61 overdue payments to 37 micro and small suppliers. The latest return was filed on 20 Apr 2024.

